These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 28541728

  • 1. Methamphetamine and psychiatry: A story of the colourless substance of abuse.
    Suetani S, Reddan J, Anderson C.
    Australas Psychiatry; 2017 Jun; 25(3):254-256. PubMed ID: 28541728
    [Abstract] [Full Text] [Related]

  • 2. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D, Greenberg MI, Miller SN, Okaneku JT, Haggerty DA.
    Dis Mon; 2012 Feb; 58(2):38-89. PubMed ID: 22251899
    [No Abstract] [Full Text] [Related]

  • 3. DARK Classics in Chemical Neuroscience: Methamphetamine.
    Abbruscato TJ, Trippier PC.
    ACS Chem Neurosci; 2018 Oct 17; 9(10):2373-2378. PubMed ID: 29602278
    [Abstract] [Full Text] [Related]

  • 4. Clinical effects and management of methamphetamine abuse.
    Romanelli F, Smith KM.
    Pharmacotherapy; 2006 Aug 17; 26(8):1148-56. PubMed ID: 16863490
    [Abstract] [Full Text] [Related]

  • 5. Amphetamine-Type Stimulants: The Early History of Their Medical and Non-Medical Uses.
    Rasmussen N.
    Int Rev Neurobiol; 2015 Aug 17; 120():9-25. PubMed ID: 26070751
    [Abstract] [Full Text] [Related]

  • 6. Methamphetamine: here we go again?
    Maxwell JC, Brecht ML.
    Addict Behav; 2011 Dec 17; 36(12):1168-73. PubMed ID: 21875772
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. History of the methamphetamine problem.
    Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S.
    J Psychoactive Drugs; 2000 Dec 17; 32(2):137-41. PubMed ID: 10908000
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of methamphetamine abuse: research findings and clinical directions.
    Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA.
    J Subst Abuse Treat; 2003 Apr 17; 24(3):267-77. PubMed ID: 12810148
    [Abstract] [Full Text] [Related]

  • 13. [Prevalence and Therapy of Crystal Methamphetamine Dependence].
    Soyka M, Koller G, Proebstl L, Kamp F, Franke A, Schmidt P, Baumgärtner G, Schacht-Jablonowsky M, Sievert A, Straif M, Hamdorf W.
    Fortschr Neurol Psychiatr; 2017 Feb 17; 85(2):92-99. PubMed ID: 28235211
    [Abstract] [Full Text] [Related]

  • 14. The world of the Haight-Ashbury speed freak.
    Smith RC, Crim D.
    J Psychoactive Drugs; 2011 Feb 17; 43(2):165-71. PubMed ID: 21858962
    [No Abstract] [Full Text] [Related]

  • 15. When treatment meets research: clinical perspectives from the CSAT Methamphetamine Treatment Project.
    Obert JL, Brown AH, Zweben J, Christian D, Delmhorst J, Minsky S, Morrisey P, Vandersloot D, Weiner A.
    J Subst Abuse Treat; 2005 Apr 17; 28(3):231-7. PubMed ID: 15857723
    [Abstract] [Full Text] [Related]

  • 16. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.
    Shoptaw S, Peck J, Reback CJ, Rotheram-Fuller E.
    J Psychoactive Drugs; 2003 May 17; 35 Suppl 1():161-8. PubMed ID: 12825759
    [Abstract] [Full Text] [Related]

  • 17. Meth--it's everybody's problem.
    Harris MH.
    S D J Med; 2003 Sep 17; 56(9):375-6. PubMed ID: 14524136
    [No Abstract] [Full Text] [Related]

  • 18. An evolving problem: methamphetamine production and trafficking in the United States.
    Shukla RK, Crump JL, Chrisco ES.
    Int J Drug Policy; 2012 Nov 17; 23(6):426-35. PubMed ID: 22943831
    [Abstract] [Full Text] [Related]

  • 19. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia.
    McKetin R, Dunlop AJ, Holland RM, Sutherland RA, Baker AL, Salmon AM, Hudson SL.
    Drug Alcohol Rev; 2013 Jan 17; 32(1):80-7. PubMed ID: 22642414
    [Abstract] [Full Text] [Related]

  • 20. Brain gain: the underground world of neuroenhancing drugs.
    Talbot M.
    New Yorker; 2009 Apr 27; ():32-43. PubMed ID: 19399986
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.